Medline Inc. Class A Common Stock (MDLN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Medline Inc. Class A Common Stock (MDLN) has a cash flow conversion efficiency ratio of 0.021x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($412.00 Million) by net assets ($19.35 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MDLN equity financing ratio to measure how much of total assets are equity-financed.
Medline Inc. Class A Common Stock - Cash Flow Conversion Efficiency Trend (2023–2025)
This chart illustrates how Medline Inc. Class A Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check MDLN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Medline Inc. Class A Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medline Inc. Class A Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Crown Castle
NYSE:CCI
|
-1.870x |
|
Jabil Circuit Inc
NYSE:JBL
|
0.305x |
|
Fiserv Inc.
NASDAQ:FISV
|
0.081x |
|
Orix Corp Ads
NYSE:IX
|
0.129x |
|
Viking Holdings Ltd
NYSE:VIK
|
0.742x |
|
Roper Technologies Inc
NASDAQ:ROP
|
0.031x |
|
EQT Corporation
NYSE:EQT
|
0.106x |
|
Gold Fields Ltd DRC
BA:GFI
|
0.048x |
Annual Cash Flow Conversion Efficiency for Medline Inc. Class A Common Stock (2023–2025)
The table below shows the annual cash flow conversion efficiency of Medline Inc. Class A Common Stock from 2023 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Medline Inc. Class A Common Stock.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $19.29 Billion | $1.74 Billion | 0.090x | -15.53% |
| 2024-12-31 | $16.52 Billion | $1.77 Billion | 0.107x | +7.86% |
| 2023-12-31 | $16.98 Billion | $1.69 Billion | 0.099x | -- |
About Medline Inc. Class A Common Stock
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front … Read more